ImageVerifierCode 换一换
格式:PPT , 页数:36 ,大小:476KB ,
资源ID:378909      下载积分:2000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-378909.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(BENZODIAZEPINES MEL POHL, MD LAS VEGAS .ppt)为本站会员(bonesoil321)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

BENZODIAZEPINES MEL POHL, MD LAS VEGAS .ppt

1、,BENZODIAZEPINESMEL POHL, MDLAS VEGAS RECOVERY CENTER,Doctors who treat the symptom tend to give a prescription; Doctors who treat the patient are more likely to offer guidance.J. Apley 1978,“Emerging research suggests that optimum benzodiazepine therapy consists of judicious, circumspect, and criti

2、cally monitored use of benzodiazepines in terms of target symptoms and diagnoses”Rickels et al,Secondary Substances for Primary Benzo Admissions,Dasis report 11/21/03,Dosage Conversion Table for Benzodiazepines Benzodiadepines Dosages (mg) Half-life* Alprazolam (Xanax) 1 6-10 Chlordiazepoxide (Libri

3、um) 25 5-100+ Clonazepam (Klonopin) .5 18-50 Clorazepate (Tranxene) 15 30-200 Diazepam (Valium) 10 30-100+ Estazolam (Prosom) 4 20-120 Flurazepam (Dalmane) 30 1-120 Midazolam (Versed) n/a Lorazepam (Ativan) 2 10-20 Oxazepam (Serax) 30 3-21 Quazepam (Doral) 30 20-120 Temazepam (Restoril) 30 10-12 Tri

4、azolam (Halcion) 1 2-3 Zolpidem (Ambien) 20 2.5 Zaleplon (Sonata) 20 1 Adapted from Giannini AJ. Drugs of abuse. 2d ed. Los Angeles: Practice Management Information Corp., 1997:121-5. *Includes metabolites - in hours,new,Short- acting,Imidazo- pyridine,Triazolo ring,Antagonist,Beta- carboline,tetrac

5、yclic,Cyclo- pyrrolone,Other sedative-hypnotics,Barbiturates - pentobarbital,phenobarbital,secobarbital, butalbital (Fiorinal) Barb-like: glutethimide, chloral hydrate, ethhchlorvynol (Placidyl), meprobamate (carisoprodol/Soma) Azapirone: buspirone (2-10 mg TID - max 60 mg/d)-slow onset of action (1

6、-3 wks)-not abused, no withdrawal-effective for anxiety disorders-not for acute-does not block benzo withdrawal -not sedating, anticonvulsant or mm relaxing-no resp dep/ cognitive/psychomotor impair,Non-Benzo Hypnotics,Zolpidem (Ambien) imadozopyridine Zaleplon (Sonata) pyrazolopyrimidine Bind to sp

7、ecifically to BZ-1 sites Both rapid onset (1h-2.5 h) - short action/1/2 life Decrease sleep latency, increase REM sleep 5-20 mg dose range Safe in older adults, metab in liver, no active metabolites Potentiate ETOH impairment Both reinforcing, potentially abusable, and performance-impairing,GHB Gamm

8、a Hydroxybutyrate,Club drug - “G” “liquid ecstasy Aqueous solution - variable concentration Relaxation, disinhibition, euphoria Rapid onset, short half-life (20 minutes) Dependence and withdrawal occur Narrow therapeutic window-side effects: Dizziness, nausea, emesis, dec resp, coma Additive with ET

9、OH and other sed-hypnotics,Therapeutic Uses,Sedative-hypnotic Anxiolytic Panic disorder Generalized anxiety disorder Muscle relaxants Anticonvulsants Alcohol withdrawal Premenstrual syndrome Psychoses Adjunct in mania of bipolar disorder,Sedative/Hypnotic,Transient - lowest effective dose- time-limi

10、ted Insignificant decrease in sleep latency-1 hour increase in sleep duration -? effect on sleeparchitecture ( REM, stages 3 and 4) Rebound insomnia - worsening of sleep - worse than before trying benzos. Daytime drowsiness, dizziness, lightheadedness,Anxiety,benzos good for immediate symptom relief

11、-fasterthan SSRIs for panic. long-acting, low potency preferred (clonazepam or chlordiazepoxide) best used for exacerbations of anxiety-short term vscontinuous use,Adverse Effects,Diminished psychomotor performance Impaired reaction time Loss of coordination, decreased attention Ataxia Falls Excessi

12、ve daytime drowsiness Confusion Amnesia Increase of existing depressed mood Overdose rarely lethal,Treatment of Overdose,Airway assessment and maintenance Ventilatory support if necessary NG suction - activated charcoal Flumazenil - competitive antagonist May need to repeat Q30-60 minutes Can induce

13、 withdrawal seizures in dependent pts.,REINFORCING EFFECTS,Increased with rapid drug effect - eg alprazolam Subjective effects - high - e.g. diazepam, lorazepam, triazolam, flunitrazepam, and alprazolam. Speed of onset of pleasurable effects - eg GHB Increased reinforcement in those with history ofd

14、rug abuse,Tolerance,Time-dependent decrease in effect. Neurochemical basis unclear Varying rates for different behavioral effects: sedative and psychomotor effects diminish first (e.g. few weeks) memory and anxiety effects persist despite chronic use. Varying rates with different benzos. If no histo

15、ry of addiction, rarely see doseescalation or overuse Cross-tolerance with ETOH and other sed-hyp,Dependence,Negative reinforcement of withdrawal - major deterrent to discontinuing use. Difficult to distinguish between wd & reboundanxiety upon discontinuing drug. Withdrawal-time-limited (not part of

16、 original anxiety state) Relapse-reemergence of original anxiety Rebound - increased anxiety baseline Also see insomnia, fatigue, headache, muscletwitching, tremor, sweating, dizziness, tinnitusdifficulty concentrating, nausea, depression, abnormal perception of movement, irritability,Dependence/Wit

17、hdrawal, cont.,rarely -seizures, delirium, confusion, psychosis. triggering of depression, mania, OCD. 90% of long-term users (8mo-1yr) experiencesignificant withdrawal insignificant wd if used less than 2 weeks mild-moderate if used 8 weeks Slow taper (30days) with +/- carbamazepine, valproic acid,

18、 trazodone, imipramine. CBT effective in dc-ing benzos and controlling panic/anxiety.,Predictors of severe withdrawal,High-potency-quickly eliminated(e.g. alprazolam, lorazepam, triazolam) higher daily dose more rapid rate of taper (esp last 50%) diagnosis of panic disorder (not GAD) high pretaper l

19、evels of anxiety and depression ETOH or other substance dependence/abuse personality pathology -e.g. neurotic or dependent Not motivated to discontinue use,Pharmacology,ABSORPTION tablets capsules some rapidly absorbed (e.g. diazepam) -morereinforcing than oxazepam or temazepam lorazepam best for IM

20、 (cdp precipitates, poorly absorbed, diazepam absorption unpredictable. lipophilic - cross blood brain barrier easily conjugated in liver- form water soluble metabolites (different metabolism for different benzos),Pharmacology,Drug Interactions: additive with other CNS depressants utilizes cytochrom

21、e P450-levels increased by-SSRIs - (less with paroxetine/Paxil, citalopram/Celexa, and sertraline/Zoloft)-ketoconazole, intraconazole -antibiotics - erythromycin-cimetidine, omeprazole-ritonavir-grapefruit juice C-P450 impaired in elderly or liver failure- inc effects,Mechanisms of Action,Benzos bin

22、d to sites on GABA-A receptors (primary inhibitory neurotransmitter in CNS) Opens chloride ion channel 20-30% of all synapses in mammalian brain endogenous benzos exist in human brain/blood chronic use - changes in gene expression on GABA-A receptor function,Benzodiazepine Abuse,Two patterns of abus

23、e - recreational abuse (nonmedical use to get high quasi-therapeutic use - long-term drug-taking inconsistent with accepted medicalPractice - multiple MDs 467 internet sites to access scheduled Rx-websites are short-lived -,CASE 1 ERIC C. Recreational Use,34 yo caucasian male, single-lives in 1/2 wa

24、y house Alprazolam 2mg - chews up to 5-10 tabs per day- Tolerance developed 4 months ago Oxycodone 10 mg - up to 20 per day Clonazepam 1mg - 6-8 per day for 2 weeks History of ETOH - 1pint/day - DC 3 months ago Withdrawal - tremors, nausea, vomiting, severeanxiety, sleeplessness, backaches, anorexia

25、, sweats Supervised release from prison in 02-on probation. Minimal depression, no SI, no psych Rx.,CASE 2 - Sharon Z. Quasi-therapeutic Use,68 yo caucasian female, married, working as a home health aide, husband is verbally abusive Lorazepam 2mg - 9-10 per day - cut back to 5mgper day because of co

26、nfrontation with daughter Ran out 2 days prior to admit - tried to get from another MD who encouraged admission WD - sever anxiety, tremor, diarrhea, neck pain, sleep disturbance, decreased energy, depression. No other substances - gambles $100/day if using pills Attempted inpatient Rx 2 yrs ago, bu

27、t left AMA SI but no plan - tried venlafaxine, caused GI distress.,Detoxification,Traditional Taper Method - using benzo Substitution and taper Anticonvulsants (possibly decrease electrical excitation in the limbic system) Carbamazepine (Tegretol) Gabapentin (Neurontin) Valproic acid (Depakote),Subs

28、titution and Taper- simple and uncomplicated,Phenobarbital, chlordiazepoxide or clonazepam Calculate equivalent dose - provide in divided dose Add prn doses of benzos during 1st week After dose stabilized, gradually reduce dose - 10% of starting dose. Slow last 25% of dose - hold to stabilize Freque

29、nt visits - withdrawal agreement,Tolerance Testing,High or erratic dose, illicit source, polysubstanceor alcohol plus benzo use. In 24-hour medically monitored setting 200 mg pentobarbital PO Q 2h - hold for intoxication, slurred speech, ataxia, somnolence. After 24-48 hrs, calculate 24 hr stabilizi

30、ng dose Give stabilizing dose for 24 hrs divided Switch to phenobarbital (30mg = 100mg pentobarbital) Initiate gradual taper,Additional Measures,Carbamazepine - decreased subjective symptoms 200 mg TID In conjunction with phenobarbital or cdp taper GI upset, neutropenia, thrombocytopenia, low Na. Va

31、lproic acid - attenuates withdrawal - GABA-ergic 250 mg TID In conjunction with phenobarbital or cdp taper Continue for 2-3 wks or more after taper Need to check LFTs prior to starting GI upset, bone marrow supression pancreatitis,Additional Measures, cont,Gabapentin - 200-300 mg TID - edema, fatigu

32、e Tiagapine (Gabitril) - gaba-ergic - Propranolol - diminish adrenergic s/s (60-120 mg/d) Clonidine - not effective Buspirone - not effective Trazadone - decreases anxiety-improve sleep - helpful CBT - improves rate of successful discontinuation and rate of abstinence from benzos,Taper Method,Slow,

33、gradual decrease in dosage (e.g. .5 mgAlprazolam every 3-5 days or as slow as .25mgEvery 7-14 days (or 10% of starting dose per wk) Last doses are hardest to eliminate - (?5% per wk) Varies from patient to patient Ambulatory setting - reliable followup Best with therapeutic-dose benzo dependence Onl

34、y benzo dependence (no other drugs/ETOH) Supportive therapy Limited Rx - withdrawal agreement,Mels Method,Phenobarbital protocol - uses modified CIWA VS and score Q 2 hrs for first 24-48 hrs. -Score 4-7 - 15 mg -Score 8-15 - 30 mg -Score 16-24 - 45 mg -Score 25-30 - 60 mg-Adjust dose upward based on symptom relief -Anticonvulsant - gabapentin, valproic acid,tiagabine -Psych eval - SSRIs, buspirone, quetiapine,

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1